Copyright
©The Author(s) 2026.
World J Immunol. Jan 8, 2026; 16(1): 111511
Published online Jan 8, 2026. doi: 10.5411/wji.v16.i1.111511
Published online Jan 8, 2026. doi: 10.5411/wji.v16.i1.111511
Table 1 Zingerone possessing various pharmacological activities
| No. | Activities | Doses | Route | Animals | Treatment duration | Ref. |
| 1 | Antioxidant | 20 mg/kg | Oral | Rats | 30 days | [20] |
| 2 | Anti-inflammatory | 100 mg/kg | Oral | Mice | 4 hours | [24] |
| 3 | Anti-cancer | 10 mg/kg | Intraperitoneal | Mice | 14 days | [8] |
| 4 | Radioprotective | 20 mg/kg | Oral | Mice | 5 days | [37] |
| 5 | Nephroprotective | 50 mg/kg | Ora | Rats | 7 days | [44] |
| 6 | Hepatoprotective | 20 mg/kg | Oral | Rats | 30 days | [52] |
| 7 | Cardioprotective | 6 mg/kg | Oral | Rats | 14 days | [60] |
| 8 | Neuroprotective | 100 mg/kg | Oral | Rats | 24 hours | [67] |
| 9 | Anti-diarrheal | 10 mg/kg | Intraluminal | Rats | - | [71] |
| 10 | Anti-microbial | 1 mg/mL | In-vitro | [76] | ||
| 11 | Anti-diabetic | 100 mg/kg | Oral | Rats | 21 days | [80] |
| 12 | Gonad-protective | 40 mg/kg and 50 mg/kg | Oral | Male mice and female rats | 35 days and 7 days | [84] |
| 13 | Ant-arthritic activity | 25 mg/kg | Oral | Rats | 21 days | [87] |
- Citation: Singh B, Singh H, Kaur S, Singh B. Preclinical pharmacology studies of zingerone with special reference to potential therapeutic applications. World J Immunol 2026; 16(1): 111511
- URL: https://www.wjgnet.com/2219-2824/full/v16/i1/111511.htm
- DOI: https://dx.doi.org/10.5411/wji.v16.i1.111511
